Long-term outcomes of the Ross procedure in adults with severe aortic stenosis: single-centre experience with 20 years of follow-up

European Journal of Cardio-thoracic Surgery

Volumn 47, Issue 1, 2015, Pages 159-167

  Kalfa, David ^a   Mohammadi, Siamak ^a   Kalavrouziotis, Dimitri ^a   Kharroubi, Mounir ^a   Doyle, Daniel ^a   Marzouk, Mohamed ^a   Metras, Jacques ^a   Perron, Jean ^a  

^a Quebec Heart and Lung Institute   (Canada)

Author keywords

Aortic valve replacement; Autograft dysfunction; Homograft dysfunction; Ross procedure

Indexed keywords

ADULT; ALLOGRAFT; AORTIC REGURGITATION; AORTIC ROOT SURGERY; AORTIC STENOSIS; AORTIC VALVE REPAIR; AORTIC VALVE REPLACEMENT; ARTICLE; AUTOGRAFT; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHICS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY RATE; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; POSTOPERATIVE MONITORING; PREOPERATIVE EVALUATION; PROPORTIONAL HAZARDS MODEL; REOPERATION; RISK ASSESSMENT; ROSS PROCEDURE; SUBCORONARY TECHNIQUE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL ANALYSIS; ADOLESCENT; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; HEART SURGERY; MIDDLE AGED; MORTALITY; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928154501     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/EJCTS/EZU038     Document Type: Article

References (25)

1. Charitos EI, Takkenberg JJ, Hanke T, Gorski A, Botha C, Franke U et al. Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross Registry. J Thorac Cardiovasc Surg 2012;144:813–21.
2. Charitos EI, Stierle U, Hanke T, Schmidtke C, Sievers HH, Richardt D. Long-term results of 203 young and middle-aged patients with more than 10 years of follow-up after the original subcoronary Ross operation. Ann Thorac Surg 2012;93:495–502.
3. Mokhles MM, Kortke H, Stierle U, Wagner O, Charitos EI, Bogers AJ et al. Survival comparison of the Ross procedure and mechanical valve replacement with optimal self-management anticoagulation therapy: propensity-matched cohort study. Circulation 2011;123:31–8.
4. Sievers HH, Stierle U, Charitos EI, Hanke T, Misfeld M, Matthias Bechtel JF et al. Major adverse cardiac and cerebrovascular events after the Ross procedure: a report from the German-Dutch Ross Registry. Circulation 2010; 122:S216–23.
5. Sievers HH, Stierle U, Charitos EI, Hanke T, Gorski A, Misfeld M et al. Fourteen years’ experience with 501 subcoronary Ross procedures: surgical details and results. J Thorac Cardiovasc Surg 2010;140:816–22.
6. David TE, Woo A, Armstrong S, Maganti M. When is the Ross operation a good option to treat aortic valve disease? J Thorac Cardiovasc Surg 2010; 139:68–73.
7. American College of Cardiology/American Heart Association Task Force on Practice G, Society of Cardiovascular A, Society for Cardiovascular A, Interventions, Society of Thoracic S et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84–231.
8. Brown JM, O’Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137: 82–90.
9. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:73–154.
10. Chikwe J, Filsoufi F, Carpentier AF. Prosthetic valve selection for middle-aged patients with aortic stenosis. Nat Rev Cardiol 2010;7:711–9.
11. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11–7.
12. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152–8.
13. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol 2009;54:1862–8.
14. Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM. Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 2006;131:558–64.
15. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet 2010;376:524–31.
16. Dagenais F, Cartier P, Voisine P, Desaulniers D, Perron J, Baillot R et al. Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J Thorac Cardiovasc Surg 2005; 129:1041–9.
17. Rizzoli G, Mirone S, Ius P, Polesel E, Bottio T, Salvador L et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg 2006;132:602–9.
18. Charitos EI, Hanke T, Stierle U, Robinson DR, Bogers AJ, Hemmer W et al. Autograft reinforcement to preserve autograft function after the ross procedure: a report from the german-dutch ross registry. Circulation 2009; 120:S146–54.
19. Kouchoukos NT. Should we still do the Ross operation in adults? Curr Opin Cardiol 2011;26:94–8.
20. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410–6.
21. Mohammadi S, Tchana-Sato V, Kalavrouziotis D, Voisine P, Doyle D, Bailllot R et al. Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis. Circulation 2012;126:S198–204.
22. Brown JW, Fehrenbacher JW, Ruzmetov M, Shahriari A, Miller J, Turrentine MW. Ross root dilation in adult patients: is preoperative aortic insufficiency associated with increased late autograft reoperation? Ann Thorac Surg 2011;92:74–81.
23. Brown JW, Ruzmetov M, Shahriari AP, Rodefeld MD, Mahomed Y, Turrentine MW. Modification of the Ross aortic valve replacement to prevent late autograft dilatation. Eur J Cardiothorac Surg 2010;37:1002–7.
24. Pretorius V, Jones A, Taylor D, Coe Y, Ross DB. Percutaneous valved stent repair of a failed homograft: implications for the Ross procedure. Can J Cardiol 2008;24:e54–5.
25. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48: 1503–10.